info@biomedres.us   +1 (720) 414-3554   One Westbrook Corporate Center, Suite 300, Westchester, IL 60154, USA   Site Map
ISSN: 2574 -1241

Impact Factor : 0.548

  Submit Manuscript

Mini ReviewOpen Access

Biotechnology and Epilepsy Patient

Volume 7 - Issue 1

Jitender Chaturvedi* and Aditya Patil

  • Author Information Open or Close
    • Department of Neurosurgery, AIIMS, Rishikesh, India

    *Corresponding author: Jitender Chaturvedi, Assistant Professor, Department of Neurosurgery, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India

Received: June 15, 2018;   Published: July 20, 2018

DOI: 10.26717/BJSTR.2018.07.001451

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

Management of patients suffering from Drug Resistant Epilepsy has changed dramatically over last few decades. Neurologists and Neurosurgeons of current generation have an advantage over past generations to have dramatically improved biotechnology to help them managing these patients. Recently, biotechnology has provided us with mobile health & wearable devices to early & promptly detect the seizures in ambulatory patients during their routine activities. This is an edge; which neuroscientists were deprived of in the past.

Abbreviations: AEDs: Antiepileptic Drugs; DRE: Drug Resistant Epilepsy; V-EEG: Video-EEG; EMG: Electromyography; SUDEP: Sudden Unexpected Death in Epilepsy

Abstract | Introduction | References |